Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutation

Portal vein thrombosis is an uncommon finding that typically arises in the context of cirrhosis. In the acute setting, it may present with abdominal pain, portal hypertension, ascites, gastrointestinal bleeding, or mesenteric ischemia. Local risk factors that predispose its formation include: cirrho...

Full description

Bibliographic Details
Main Authors: Rahul Rao, BS, John Grosel, MD
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:Radiology Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043318302486
id doaj-dee497fbc68d4e8680fa5a3392083405
record_format Article
spelling doaj-dee497fbc68d4e8680fa5a33920834052020-11-24T21:04:01ZengElsevierRadiology Case Reports1930-04332018-12-0113612491255Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutationRahul Rao, BS0John Grosel, MD1West Virginia School of Osteopathic Medicine, Lewisburg, WV, United StatesRiverside Radiology and Interventional Associates, Inc., Associate Professor Marietta College PA Program, 401 Matthew St. Marietta, OH 45750, United States; Corresponding author.Portal vein thrombosis is an uncommon finding that typically arises in the context of cirrhosis. In the acute setting, it may present with abdominal pain, portal hypertension, ascites, gastrointestinal bleeding, or mesenteric ischemia. Local risk factors that predispose its formation include: cirrhosis, hepatocellular carcinoma, pancreatitis, and intraabdominal infection. Systemic factors, including hypercoagulable states and sepsis, also pose an increased risk. JAK2 V617F positive myeloproliferative disorders are associated with systemic prothrombotic states and are a less frequently identified cause of portal vein thrombosis. We present a case of acute unprovoked portal vein thrombosis diagnosed in a 59-year-old male without local disease factors. Computed tomography, magnetic resonance cholangiopancreatography, and ultrasound demonstrated the presence of portal vein thrombosis with neighboring periportal and pancreatic head edema. Peripheral blood testing detected the presence of JAK2 V617F mutation. The patient was discharged on 6-month anticoagulation therapy and outpatient follow-up. Keywords: Portal vein thrombosis, JAK2 V617Fhttp://www.sciencedirect.com/science/article/pii/S1930043318302486
collection DOAJ
language English
format Article
sources DOAJ
author Rahul Rao, BS
John Grosel, MD
spellingShingle Rahul Rao, BS
John Grosel, MD
Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutation
Radiology Case Reports
author_facet Rahul Rao, BS
John Grosel, MD
author_sort Rahul Rao, BS
title Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutation
title_short Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutation
title_full Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutation
title_fullStr Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutation
title_full_unstemmed Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutation
title_sort acute portal vein thrombosis in a 59-year-old male with jak2 v617f mutation
publisher Elsevier
series Radiology Case Reports
issn 1930-0433
publishDate 2018-12-01
description Portal vein thrombosis is an uncommon finding that typically arises in the context of cirrhosis. In the acute setting, it may present with abdominal pain, portal hypertension, ascites, gastrointestinal bleeding, or mesenteric ischemia. Local risk factors that predispose its formation include: cirrhosis, hepatocellular carcinoma, pancreatitis, and intraabdominal infection. Systemic factors, including hypercoagulable states and sepsis, also pose an increased risk. JAK2 V617F positive myeloproliferative disorders are associated with systemic prothrombotic states and are a less frequently identified cause of portal vein thrombosis. We present a case of acute unprovoked portal vein thrombosis diagnosed in a 59-year-old male without local disease factors. Computed tomography, magnetic resonance cholangiopancreatography, and ultrasound demonstrated the presence of portal vein thrombosis with neighboring periportal and pancreatic head edema. Peripheral blood testing detected the presence of JAK2 V617F mutation. The patient was discharged on 6-month anticoagulation therapy and outpatient follow-up. Keywords: Portal vein thrombosis, JAK2 V617F
url http://www.sciencedirect.com/science/article/pii/S1930043318302486
work_keys_str_mv AT rahulraobs acuteportalveinthrombosisina59yearoldmalewithjak2v617fmutation
AT johngroselmd acuteportalveinthrombosisina59yearoldmalewithjak2v617fmutation
_version_ 1716772344139087872